YU46701B - Postupak u za dobijanje osnovnog nosećeg materijala za dozne oblike lekova sa produženim izdvajanjem aktivne supstance - Google Patents

Postupak u za dobijanje osnovnog nosećeg materijala za dozne oblike lekova sa produženim izdvajanjem aktivne supstance

Info

Publication number
YU46701B
YU46701B YU230888A YU230888A YU46701B YU 46701 B YU46701 B YU 46701B YU 230888 A YU230888 A YU 230888A YU 230888 A YU230888 A YU 230888A YU 46701 B YU46701 B YU 46701B
Authority
YU
Yugoslavia
Prior art keywords
procedure
active substance
extended release
supporting material
dosage forms
Prior art date
Application number
YU230888A
Other languages
English (en)
Other versions
YU230888A (en
Inventor
N.G. Gaylord
A. Nigalaye
Original Assignee
Forest Laboratories Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forest Laboratories Inc. filed Critical Forest Laboratories Inc.
Publication of YU230888A publication Critical patent/YU230888A/xx
Priority to HR920377A priority Critical patent/HRP920377A2/hr
Publication of YU46701B publication Critical patent/YU46701B/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)

Abstract

POSTUPAK U ZA DOBIJANJE OSNOVNOG NOSEĆEG MATERIJALA ZA DOZNE OBLIKE LEKOVA SA PRODUŽENIM IZDVAJANJEM AKTIVNE SUPSTANCE, naznačen time, što se priprema smeša koja, od bitnih komponenata, sadrži karboksilat alkalnog metala i jedan ili više u vodi rastvornih nejonskih celuloznih etara od kojih je bar jedan hidroksipropilmetil-celuloza prosečne molekulske težine od najmanje 50 000. Prijava sarži još 5 zavisnih zahteva.
YU230888A 1987-12-21 1988-12-20 Postupak u za dobijanje osnovnog nosećeg materijala za dozne oblike lekova sa produženim izdvajanjem aktivne supstance YU46701B (sh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HR920377A HRP920377A2 (en) 1987-12-21 1992-09-21 Process for the preparatin of a carrier base material for drug dosage forms with an extended release of active substance

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13566787A 1987-12-21 1987-12-21
US07/284,931 US4983398A (en) 1987-12-21 1988-12-15 Sustained release drug dosage forms containing hydroxypropylmethylcellulose and alkali metal carboxylates

Publications (2)

Publication Number Publication Date
YU230888A YU230888A (en) 1990-02-28
YU46701B true YU46701B (sh) 1994-04-05

Family

ID=26833549

Family Applications (1)

Application Number Title Priority Date Filing Date
YU230888A YU46701B (sh) 1987-12-21 1988-12-20 Postupak u za dobijanje osnovnog nosećeg materijala za dozne oblike lekova sa produženim izdvajanjem aktivne supstance

Country Status (9)

Country Link
US (1) US4983398A (sh)
EP (1) EP0322222B1 (sh)
JP (1) JPH0791183B2 (sh)
CA (1) CA1331344C (sh)
DE (1) DE3867619D1 (sh)
DK (1) DK710788A (sh)
ES (1) ES2045153T3 (sh)
NZ (1) NZ227428A (sh)
YU (1) YU46701B (sh)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6129930A (en) 1993-09-20 2000-10-10 Bova; David J. Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night
US6818229B1 (en) 1993-09-20 2004-11-16 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia
US6080428A (en) 1993-09-20 2000-06-27 Bova; David J. Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
US6676967B1 (en) 1993-09-20 2004-01-13 Kos Pharmaceuticals, Inc. Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
US20060263428A1 (en) * 1993-09-20 2006-11-23 Eugenio Cefali Methods for treating hyperlipidemia with intermediate release nicotinic acid compositions having unique biopharmaceutical characteristics
US6746691B2 (en) 1993-09-20 2004-06-08 Kos Pharmaceuticals, Inc. Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
US6239172B1 (en) * 1997-04-10 2001-05-29 Nitrosystems, Inc. Formulations for treating disease and methods of using same
GB9611328D0 (en) * 1996-05-31 1996-08-07 Zeneca Ltd Pharmaceutical compositions
US5968895A (en) * 1996-12-11 1999-10-19 Praecis Pharmaceuticals, Inc. Pharmaceutical formulations for sustained drug delivery
US7179486B1 (en) 1997-04-01 2007-02-20 Nostrum Pharmaceuticals, Inc. Process for preparing sustained release tablets
US6210710B1 (en) 1997-04-28 2001-04-03 Hercules Incorporated Sustained release polymer blend for pharmaceutical applications
US5948440A (en) * 1997-12-17 1999-09-07 Ranbaxy Laboratories Limited Modified release matrix formulation of cefaclor and cephalexin
US6143325A (en) * 1998-06-05 2000-11-07 Bristol-Myers Squibb Company Nefazodone dosage form
US6986898B1 (en) * 1999-06-28 2006-01-17 Ecosmart Technologies, Inc. Synergistic and residual pesticidal compositions containing plant essential oils with enzyme inhibitors
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US6955821B2 (en) * 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US6372252B1 (en) 2000-04-28 2002-04-16 Adams Laboratories, Inc. Guaifenesin sustained release formulation and tablets
US6476006B2 (en) 2000-06-23 2002-11-05 Teva Pharmaceutical Industries, Ltd. Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
US6881420B2 (en) * 2000-06-23 2005-04-19 Teva Pharmaceutical Industries Ltd. Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation
US7674480B2 (en) * 2000-06-23 2010-03-09 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
FR2823974B1 (fr) * 2001-04-25 2004-10-15 Pf Medicament Pastille medicamenteuse a liberation lente du principe actif
US20030203055A1 (en) * 2002-03-15 2003-10-30 Cypress Bioscience, Inc. Methods of treating visceral pain syndromes
US20060003004A1 (en) * 2002-10-25 2006-01-05 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
US20040132826A1 (en) * 2002-10-25 2004-07-08 Collegium Pharmaceutical, Inc. Modified release compositions of milnacipran
WO2004067039A1 (en) * 2003-01-28 2004-08-12 Collegium Pharmaceutical, Inc. Multiparticulate compositions of milnacipran for oral administration
US7985418B2 (en) * 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
WO2007027566A2 (en) * 2005-09-02 2007-03-08 Genzyme Corporation Method for removing phosphate and polymer used therefore
PT1924246E (pt) 2005-09-15 2016-02-10 Genzyme Corp Formulação sachê para polímeros com funcionalidade amina
EP2016114A2 (en) * 2006-05-05 2009-01-21 Genzyme Corporation Amine condensation polymers as phosphate sequestrants
EP2049014A2 (en) * 2006-07-18 2009-04-22 Genzyme Corporation Amine dendrimers
JP2010504975A (ja) 2006-09-29 2010-02-18 ゲンズイメ コーポレーション アミドデンドリマー組成物
BRPI0720234A2 (pt) 2006-12-14 2013-12-24 Genzyme Corp Composição farmacêutica
WO2008103368A1 (en) * 2007-02-23 2008-08-28 Genzyme Corporation Amine polymer compositions
JP2010520285A (ja) * 2007-03-08 2010-06-10 ゲンズイメ コーポレーション スルホンポリマー組成物
EP2152277A1 (en) * 2007-04-27 2010-02-17 Genzyme Corporation Amido-amine dendrimer compositions
KR100742093B1 (ko) * 2007-05-10 2007-07-24 인하대학교 산학협력단 엔티알유 암호화 및 복호화를 위한 다항식 컨볼루션 연산방법
WO2009078958A1 (en) * 2007-12-14 2009-06-25 Genzyme Corporation Coated pharmaceutical compositions
US20110142952A1 (en) * 2008-06-20 2011-06-16 Harris David J Pharmaceutical Compositions
KR101713810B1 (ko) * 2009-01-23 2017-03-09 아지엔드 키미쉐 리유나이트 안젤리니 프란체스코 에이.씨.알.에이.에프. 에스.피.에이 제어 방출형 약학적 제제 또는 식품 제제 및 이의 제조 방법
TWI478733B (zh) * 2009-05-13 2015-04-01 Wyeth Llc 突釋藥物釋放組合物
CA3001337C (en) 2015-10-09 2023-12-12 Reckitt Benckiser Llc Pharmaceutical formulation
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065143A (en) * 1960-04-19 1962-11-20 Richardson Merrell Inc Sustained release tablet
US3590117A (en) * 1969-03-24 1971-06-29 Richardson Merrell Inc Long-lasting troche containing guar gum
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
US4126672A (en) * 1976-02-04 1978-11-21 Hoffmann-La Roche Inc. Sustained release pharmaceutical capsules
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4540566A (en) * 1984-04-02 1985-09-10 Forest Laboratories, Inc. Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
GB2176999B (en) * 1985-06-22 1989-07-12 Stanley Stewart Davis Sustained release medicament

Also Published As

Publication number Publication date
DE3867619D1 (de) 1992-02-20
US4983398A (en) 1991-01-08
EP0322222A1 (en) 1989-06-28
CA1331344C (en) 1994-08-09
JPH02204A (ja) 1990-01-05
EP0322222B1 (en) 1992-01-08
JPH0791183B2 (ja) 1995-10-04
DK710788A (da) 1989-06-22
DK710788D0 (da) 1988-12-20
ES2045153T3 (es) 1994-01-16
NZ227428A (en) 1989-12-21
YU230888A (en) 1990-02-28

Similar Documents

Publication Publication Date Title
YU46701B (sh) Postupak u za dobijanje osnovnog nosećeg materijala za dozne oblike lekova sa produženim izdvajanjem aktivne supstance
KR890004686A (ko) 서방성 에토돌락
BG102254A (en) Oral fast soluble compositions as dopamine antagonists
IL85523A (en) Stable alpha interferon complex,its preparation and pharmaceutical compositions comprising it
MY101545A (en) Continuous release pharmaceutical compositions.
IT8720650A0 (it) Derivati dell'etere immidazochinolinilico ad azione farmaceutica e procedimento per laloro preparazione.
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
ZA837412B (en) Compressed products with retarded release of active substance
IL87019A0 (en) Substituted alkene carboxylic acid amides and derivatives,their manufacture and pharmaceutical compositions containing them
ES8705763A1 (es) Procedimiento para preparar nuevas formulaciones de gel parafines terapeuticos y diagnosticos
HU895241D0 (en) Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient
ES2060293T3 (es) Nueva sustancia antiulcerosa.
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
ZA871145B (en) Compositions for the release of biologically active substances into desired environments
FR2641276B1 (fr) Derives du benzene, leur preparation et les compositions pharmaceutiques en contenant
IT8449056A0 (it) Derivati dell'1,2-ditiolano,loro preparazione e loro impiego come medicamenti
IT8024152A0 (it) Derivati dell'1,1,2-trifenilpropano e dell'1,1,2-trifenilpropene, procedimento per la loro preparazione e composizioni farmaceutiche contenenti i composti
IT8103423A0 (it) Derivati di alcandioli conattivita' ipolipidemizzante, metodi per la loro preparazione e composizioni farmaceutiche che licontengono
IT1196494B (it) Derivati dell'acito cef-3-em-4-carbossilico,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT8720271A0 (it) Nuovi derivati dell'ergolene, composizioni farmaceutiche che licontengono e procedimento per lapreparazione dei medesimi.
IT8548898A0 (it) Derivati dell'1,4-diidropiridina,loro preparazione e loro impiego come medicamenti
IT1186775B (it) Derivati nuobosidici aventi proprieta' antierpetiche,composizioni farmaceutiche che li contengono e procedimento per la preparazione degli ingredienti attivi
IT8619005A0 (it) Derivati idrosolubili dell'acido 4,5 -difenil- 2 -ossazolpropionico, loro preparazione ed utilizzo in composizioni farmaceutiche.
ZA901978B (en) Substituted azetidinylpyridonecarboxylic acid derivatives,their preparation and their application as medicinal products